Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-11-24 Equity Swap | 2021-11-24 4:11 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | BIGHAM MICHAEL Director | 10,000 | $0 | 0 (Direct) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:11 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | MAHONEY DAVID L Director | 117,781 | $0 | 0 (Direct) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:10 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | McFarlane Neil F. Chief Executive Officer | 600,000 | $0 | 0 (Direct) | View |
| 2021-11-24 Option Award | 2021-11-24 4:10 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | McFarlane Neil F. Chief Executive Officer | 75,000 | $0 | 0 (Direct) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:10 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer | 163,767 | $0 | 0 (Direct) | View |
| 2021-11-24 Option Award | 2021-11-24 4:10 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Prentiss Christopher B Chief Financial Officer | 18,750 | $0 | 0 (Direct) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:09 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Ericson William W. Director 10% Owner | 4,629,796 | $0 | 0 (Direct) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:09 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Shreedhar Vijay Chief Commercial Officer | 186,786 | $0 | 0 (Direct) | View |
| 2021-11-24 Option Award | 2021-11-24 4:09 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Shreedhar Vijay Chief Commercial Officer | 18,750 | $0 | 0 (Direct) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:09 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | Papapetropoulos Spyridon Director | 20,975 | $0 | 0 (Direct) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:08 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | RICHO ANNA Director | 25,000 | $0 | 0 (Direct) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:08 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | DEMSKI MARTHA J Director | 21,000 | $0 | 0 (Indirect) | View |
| 2021-11-24 Equity Swap | 2021-11-24 4:07 pm | N/A N/A | Adamas Pharmaceuticals Inc | ADMS | MacPhee John A Director | 202,000 | $0 | 0 (Direct) | View |